The prognostic molecular markers in hepatocellular carcinoma. - Wikidata - wikimedia - TriplyDB

The prognostic molecular markers in hepatocellular carcinoma.

The prognostic molecular markers in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34668320

about

Angiogenesis in male breast cancer Targeting Hepatocellular Carcinoma: What did we Discover so Far?Staging of hepatocellular carcinoma Isolation of a novel member of small G protein superfamily and its expression in colon cancer Tumor suppressor and hepatocellular carcinoma Effect of arsenic trioxide on rat hepatocellular carcinoma and its renal cytotoxity Effects of hydroxyapatite nanoparticles on proliferation and apoptosis of human hepatoma BEL-7402 cells From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis.Expressed proteome analysis of human hepatocellular carcinoma in nude mice (LCI-D20) with high metastasis potential.Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma The regulation of non-coding RNA expression in the liver of mice fed DDC.Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma The role of cytokines in UbD promoter regulation and Mallory-Denk body-like aggresomes Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines.Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma.Role of lifeguard β-isoform in the development of breast cancer.Decreased expression of BATF2 is associated with a poor prognosis in hepatocellular carcinoma.Structure analysis and expressions of a novel tetratransmembrane protein, lysosoma-associated protein transmembrane 4 beta associated with hepatocellular carcinoma.Clinical significance of the expression of isoform 165 vascular endothelial growth factor mRNA in noncancerous liver remnants of patients with hepatocellular carcinoma.Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.Reduction of metastatic and angiogenic potency of malignant cancer by Eupatorium fortunei via suppression of MMP-9 activity and VEGF production.Decoding global gene expression programs in liver cancer by noninvasive imaging.Tumor angiogenesis after heated lipiodol infusion via the hepatic artery in a rabbit model of VX2 liver cancer Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues.Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma.Liver angiogenesis as a risk factor for hepatocellular carcinoma development in hepatitis C virus cirrhotic patients.Roles of main pro- and anti-angiogenic factors in tumor angiogenesis The role of Fas ligand and transforming growth factor beta in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy.Oxidation of heat shock protein 60 and protein disulfide isomerase activates ERK and migration of human hepatocellular carcinoma HepG2.HAX-1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma Expression of IGF-II in early experimental hepatocellular carcinomas and its significance in early diagnosis.Synergistic effects of nimesulide and 5-fluorouracil on tumor growth and apoptosis in the implanted hepatoma in mice.Gene expression profiles of hepatoma cell line HLE.Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinoma

P2860

Q24803467-754FB494-CD9B-42FE-AE00-01A6F02E3592 Q28077283-9E09D490-89F6-4021-8292-AEF743109725 Q28081265-924A2ED2-97A4-45E8-B946-86AA970FFB5D Q28201755-588E6B3C-D9F7-4E10-8BCE-C2FDE94D119E Q28389231-3DC4C7F1-B0B5-4A9E-B463-5882EACB93AB Q30921046-972958A3-B6E6-4557-89EA-1087251C762F Q33188513-2EC805F1-9761-41C8-9A92-DC5DEA23D0CC Q33194407-CC1B2D75-2E9C-452F-A1C9-E838DF2F5450 Q33230149-EF0210F7-68D5-4BA7-BE05-0BB85F04FC0D Q33866121-BB5385A4-F3FB-4352-BFA4-AB3FF3F93BC9 Q33911063-826150E7-F073-4239-958C-293FD2EC020A Q33967757-78DED223-6D9D-42DE-80F0-0DCB93211E80 Q33973729-6DD16942-E413-4731-BE65-873DF5ECCAD2 Q33977054-56D53FE8-0687-4DDE-8386-EAC1ECF5FDE4 Q34016378-A51B67A8-2261-4FF3-98F5-8A1FBE33FBAC Q34029258-E8AC48DA-CFD8-4455-8043-6CB8E52EB449 Q34105179-08756C2A-68CF-45E2-935D-7963C5C16D01 Q34115719-CEABAA2D-90C4-4B82-BBD1-3BF8A57284A1 Q34322940-D35A05FB-B132-4D37-975D-D764493391C4 Q34382605-75374FE5-71CA-49C9-BF34-FA12D4D7DA8B Q34382649-AB7EE39B-BEDA-416D-B60C-EB4205FCFE46 Q34485591-7D713BA3-E064-4F5B-81CB-A5E18AE3028F Q34630291-CBED608F-110C-459E-9554-83F71A26927E Q34700446-9B1BCA5B-7DDB-40F4-8F24-A394DBD6E53F Q35101345-B25773D0-F444-4A00-8418-200C56E7F4ED Q35113002-1CF9E697-632F-45ED-9180-62D42EF6033B Q35165994-0CD7D878-6867-4232-ACA3-228A9D91195E Q35588545-C95FE7BA-B046-4370-9B72-09CDCA42B5D5 Q35615755-F3FB3A01-00C6-4385-8C70-2E0B58F8A347 Q35668936-9B1D0B2B-7D27-4448-8273-7D7A16D02BC9 Q35782195-09960DC1-276A-44FF-84D7-99F985493C6D Q35913323-81D43569-A1A6-43F0-8910-13655C1F9464 Q36014285-E905745A-7CD3-4B3F-A6AF-9FF62A7D4079 Q36114523-CB99FE89-046B-4521-9656-D9AFFF3119BD Q36178311-229E7285-8279-4314-B37A-470687EECB0E Q36178548-926610AD-9AAD-4F2B-BF12-2138B6A79650 Q36178624-3378A282-68B2-439B-888E-1FDDBD91281B Q36178628-F4049241-D3DE-4985-AEB6-1932F08ED8A9 Q36180620-83582821-40D3-423E-90D6-F692F045D337 Q36190335-A0196B9D-98B8-4D3B-8398-358CF9F91C52

P2860

The prognostic molecular markers in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34668320

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The prognostic molecular markers in hepatocellular carcinoma.

@ast

The prognostic molecular markers in hepatocellular carcinoma.

@en

The prognostic molecular markers in hepatocellular carcinoma.

@nl

type

label

The prognostic molecular markers in hepatocellular carcinoma.

@ast

The prognostic molecular markers in hepatocellular carcinoma.

@en

The prognostic molecular markers in hepatocellular carcinoma.

@nl

prefLabel

The prognostic molecular markers in hepatocellular carcinoma.

@ast

The prognostic molecular markers in hepatocellular carcinoma.

@en

The prognostic molecular markers in hepatocellular carcinoma.

@nl

P1433

Q34668320-B8831D7B-8FCC-4932-81B5-2263187AC2C2

P1476

Q34668320-AC027FA9-2459-4F66-AD7B-F32FB73F5E77

P2093

Q34668320-3EF04628-767A-434C-A2AD-2B50A1615225

Q34668320-A9122D5A-BA97-4CBD-AF2F-A81BF7228E56

P2860

Q34668320-00C835A3-AFFB-4001-AB7F-B3D102E3E5DF

Q34668320-07C3AD9E-6237-4EB3-851C-DB49C64AC79C

Q34668320-0876E3CD-9742-4F90-A279-064EA46AD742

Q34668320-08CADAD5-983E-497C-AB61-1E90350D6FBD

Q34668320-0A1D2066-3EAE-4A8C-9A64-3E34DE088E45

Q34668320-0A6934D5-4183-4D39-96A2-FFD2E25147E5

Q34668320-0EA36F2B-6759-4E99-A683-850EB8D50EBE

Q34668320-0F4A5B2A-0785-4E22-B9A1-17C4328A70D0

Q34668320-0FE4A288-7AB1-4BD5-A30B-2F2367672228

Q34668320-106A09E8-0043-425B-BB46-2687C820179C

P304

Q34668320-0255471C-E4D9-48CE-9DB8-C89BE4B17A6D

P31

Q34668320-FEE7D8F4-6A92-45F1-B6F7-F5D4A527AB7B

P356

Q34668320-5A35F7CC-2AE2-43D0-A410-106FD7360492

P407

Q34668320-BF9D7FB4-0D30-431D-9E58-20F0FA4B60A5

P433

Q34668320-C245D79A-7A65-49F6-A5BE-11A81C55B5C5

P478

Q34668320-8091F975-98F4-4D2A-95BF-C27B15BF7D5C

P577

Q34668320-DFD29626-D056-405A-BED1-AC1344C6295F

P5875

Q34668320-5C01DE1B-D94E-4C2B-8FDB-37B635B74A0B

P698

Q34668320-179727A0-F1AE-435E-B63E-68F48D712812

P932

Q34668320-818EC1F8-BDFB-456C-8575-FE0876D9187A

P356

P1433

World Journal of Gastroenterology

P1476

The prognostic molecular markers in hepatocellular carcinoma.

@en

P2093

Lun-Xiu Qin

http://www.w3.org/2001/XMLSchema#string

Zhao-You Tang

http://www.w3.org/2001/XMLSchema#string

P2860

CD44 cell adhesion molecules

Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis

Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.

The Ki-67 protein: from the known and the unknown

RECK gene expression in hepatocellular carcinoma: correlation with invasion-related clinicopathological factors and its clinical significance. Reverse-inducing--cysteine-rich protein with Kazal motifs.

Clinical implications of circulating angiogenic factors in cancer patients.

Enhanced expression of cyclin E and cyclin A in human hepatocellular carcinomas.

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.

Circulating DNA in plasma or serum.

The challenge of p53 as prognostic and predictive factor in Hodgkin's or non-Hodgkin's lymphoma.

P304

385-392

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V8.I3.385

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11327399

http://www.w3.org/2001/XMLSchema#string

P698

12046056

http://www.w3.org/2001/XMLSchema#string

P932

4656407

http://www.w3.org/2001/XMLSchema#string